Prof Mike Chan Highlights the Future of Bioregenerative Medicine at Chengdu’s Global Medical Innovation Summit

CHENGDU, China (March 5, 2026) — Scientists, physicians and biotechnology innovators from around the world gathered in Chengdu this week for the China International Medical Tourism Fair (CIMTF) and the International Medical Innovation and Cell Biology Conference, held at the Century City International Convention and Exhibition Center, one of western China’s largest convention venues.

The event — regarded as one of Asia’s growing platforms for dialogue on regenerative medicine, medical tourism and biomedical innovation — brought together researchers, hospital leaders, biotechnology companies and global medical experts to examine the future of healthcare, from stem cell therapies and longevity science to artificial intelligence in medicine.

At the center of the discussion was Prof. Dato’ Sri Dr. Mike Chan, founder of the European Wellness Biomedical Group, who delivered two keynote-style lectures on the opening day of the conference to a full-house auditorium, drawing strong interest from delegates eager to understand the future of precision regenerative medicine.

The talks took place during the China International Medical Tourism Fair (CIMTF) and International Medical Innovation Conference, one of Asia’s emerging platforms for collaboration between global researchers, hospitals, biotechnology companies and investors working at the frontier of next-generation healthcare.

Also speaking during the Day 1 program was Prof. Dr. Yuriy Nalapko, a regenerative medicine specialist representing European Wellness, who shared insights into clinical applications of cellular therapies.

A Global Platform for the Future of Medicine

The Chengdu forum forms part of a national series of biomedical conferences and exhibitions held across major Chinese cities, bringing together leaders in biotechnology, regenerative medicine, artificial intelligence and medical tourism.

Over two days, the conference features parallel sessions covering cutting-edge topics such as:

• Stem cell and regenerative therapies
• Artificial intelligence in medical diagnostics
• Longevity and anti-aging science
• Cross-border healthcare and medical tourism
• Commercialization of biotechnology research
• Precision medicine and targeted cellular treatments

The event also includes a large medical technology exhibition where biotechnology companies, hospitals and research institutions present emerging therapies and technologies.

Experts say the forum reflects a broader transformation taking place in global healthcare.

As populations age and chronic diseases become more prevalent, scientists are increasingly exploring therapies capable of repairing damaged tissues and restoring cellular function, rather than simply managing symptoms.

Precision Regenerative Medicine

During his lectures, Prof Chan focused on what he calls precision regenerative medicine — a targeted approach to treatment that matches specific stem cells and peptides to damaged organs.

“There are more than 400 different types of stem cells and biologically active peptides in the human body,” Prof Chan told the packed auditorium.

“Each one has a specialized role. The key to regenerative medicine is understanding how to use the right cell for the right organ at the right time.”

He explained that the human body constantly repairs itself through cellular communication and regeneration — processes that modern medicine is only beginning to understand and harness.

“For many decades, medicine has focused on treating symptoms,” he said.

“But the future of healthcare lies in restoring biological function — repairing the tissues and cells that have deteriorated.”

Moving Beyond Symptom Management

Prof Chan told delegates that regenerative medicine is gradually shifting the paradigm of healthcare from reactive treatment to biological restoration and prevention.

“The goal is not only to treat disease,” he said.

“The real goal is to restore health at the cellular level, allowing the body to regain its natural capacity to repair itself.”

He noted that advances in stem cell science, peptide signaling and molecular medicine are making it possible to develop therapies that target organs with unprecedented precision.

“These are not general treatments,” he said.

“They are organ-specific regenerative protocols designed to restore function to damaged tissues.”

A Catalyst for Global Collaboration

The strong turnout at Prof Chan’s sessions reflected the growing interest among medical professionals and researchers in regenerative therapies.

Organizers said the Chengdu conference aims to accelerate collaboration between international experts and China’s rapidly expanding biotechnology ecosystem.

For many participants, the event serves as a catalyst for advancing bioregenerative medicine, a field combining stem cell therapy, molecular biology and advanced biotechnology.

Prof Chan told delegates that collaboration between scientists, clinicians and technology innovators will be essential in bringing regenerative therapies to patients worldwide.

“Breakthroughs in medicine rarely happen in isolation,” he said.

“They happen when scientists, doctors and innovators come together to exchange ideas and build solutions.”

Toward a New Era of Healthcare

As the conference continues with additional scientific panels and industry forums, many experts say the conversations taking place in Chengdu point to a major shift in global healthcare.

Regenerative medicine — once considered experimental — is increasingly being viewed as a core pillar of future medicine.

For Prof Chan, the implications are profound.

“We are witnessing the early stages of a new medical era,” he said.

“An era where medicine will not only treat disease, but repair, regenerate and restore the human body itself.”